Abstract: The present invention provides a method of use for a hydrogen peroxide-forming oxidase, wherein the enzyme is obtained from Streptomycetaceae and at 25.degree. C., in 0.15 mol/liter potassium phosphate (pH 7.9), in the presence of surface-active substances, still shows after 2 days an activity of at least 40% of the initial activity. This enzyme is useful in the determination of sarcosine, creatine and creatinine.

Abstract: The present invention is concerned with the use of aniline derivatives of the general formula: ##STR1## wherein R.sup.1 is a hydrogen atom or a --(CH.sub.2).sub.n --X radical, in which n is a whole number of from 1 to 3, X is H, OH, NH.sub.2, CH.sub.3 CONH, CH.sub.3 SO.sub.2 NH, COOH, SO.sub.3 H or --ArSO.sub.3 H, Ar being an optionally substituted arylene radical, m is a whole number of from 2 to 4, R.sup.3 is a hydrogen atom, an alkyl radical containing up to 3 carbon atoms, OCH.sub.3, CH.sub.3 CONH, COOH or SO.sub.3 H and R.sup.4 is a hydrogen, chlorine or bromine atom or a carboxylic acid or sulphonic acid group, as coupling components in oxidative color formation reactions.The present invention also provides an agent for the analytical determination of oxidizing substances by oxidative color coupling which, as coupling component, contains at least one compound of general formula (I).

Abstract: This invention teaches a process for preparing a conjugate useful in enzyme immunoassays, and the conjugate produced by the process. The process involves oxidizing an enzyme containing a carbohydrate portion, such as peroxidase, with periodic acid or an alkali metal salt thereof in an aqueous medium followed by reduction with sodium borohydride. The oxidation and reduction step may be carried out either before or after the enzyme is coupled to the immunologically effective component of the conjugate.

Abstract: The present invention provides a process for the quantitative determination of free thyroxine (FT.sub.4) in plasma, serum or whole blood by immunological methods, wherein the sample is incubated for at most 10 minutes with a 10 to 2000 fold insufficiency of labelled anti-T.sub.4 antibodies, referred to the molar amount of total T.sub.4 in the sample, then immediately brought together with immobilized excess T.sub.4, again incubated, the phases separated and the label measured in one of the phases.

Abstract: The present invention teaches a restriction endonuclease which recognizes and cleaves palindromic sequence5'Pu G G N C C Py 3'3'Py C C N G G Pu 5'as well as a process for obtaining this endonuclease. One source of the endonuclease is Deinococcus radiophilus DSM 20551 (ATCC 27063). The endonuclease is useful in analysis of DNA molecules.

Abstract: A process for culturing biological material capable of multiplication, especially cells securely adhering to microcarriers, employs a bioreactor having a vessel for a culture medium having means for controlling the environmental conditions in the culture medium and a stirring device for the homogeneous distribution of the cells in the culture medium which has a rotary drive and a rotation axle running in the interior of the vessel, wherein the stirring device has at least one flat stirrer blade fixed on to the rotation axle and inclined to the rotation axle.

Abstract: The present invention provides a test carrier (1) for the analytical determination of a component of a body fluid with a base layer (2) and at least two planar test layers which, in the initial state of the test carrier, before carrying out the determination, are separate from one another but can be brought into contact with one another by external manipulation, wherein a first test layer (8) and a second test layer (10) are arranged on the base layer essentially next to one another but separated in the initial state by a gap, a contact element (11, 17, 18, 20) being provided which consists of a capillary-active material which is so dimensioned that it can bridge the gap (12) and which is so mounted and arranged that, in a first position, it cannot contact at least one of the test layers (8, 10) but, by external pressure, it can be brought into a second position in which it contacts both test layers in such a manner that a liquid exchange between the test layers is possible.

Abstract: The present invention provides a device for the electrochemical analysis of electrolytic components in a sample liquid (58), especially of a body fluid, with a selective measurement electrode (20) for a kind of ion to be analysed, a reference half cell, which includes a conducting-off element (30) cooperating in the operational state with a reference electrolyte (56), and a voltage measurement device (34) for the measurement of the voltage between the measurement electrode and the conducting-off element (30), wherein the measurement electrode (20) is arranged on a pipe (22) provided with a sucking-in opening (23) for the sample liquid (58), the conducting-off element (30) of the reference half cell being arranged on the pipe (22) in such a manner that it directly contacts a liquid (56) present therein, the conducting-off element (30) thereby being arranged in the pipe (22) in the sucking-in direction behind the measurement electrode (20), a sucking-in device (36) being provided through which a sample liquid (

Abstract: The present invention provides a container for test strips for the analysis of body fluids, comprising a container body (2) with a circular removal opening (2a), a sealing surface (14) facing the axis (A) of the opening and a stopper (3) for the closure of the removal opening (2a) which has a cover plate (4), a hollow plug (7) attached thereto with an outwardly facing sealing beading (8), a drying agent cell (6) within the hollow plug and a support element (10) by means of which the plug is supported radially inwardly, wherein the support element is so constructed that it abuts the hollow plug in a region axially displaced away from the cover plate (4) with regard to the zenithal line (15) of the sealing beading (8), whereas axially, at the height of the sealing beading (8), between the inner side of the hollow plug and the drying agent cell, even when the stopper (3) is in a position permitting removal, an annular gap (9 ) is present so that the hollow plug (7) is radially inwardly elastically deformable in

Abstract: The present invention provides Indolines of the formula: ##STR1## ps useful to provide pharmaceutically active pyrrolobenzimidazoles or tautomers thereof, of the formula: These compounds are useful for treating heart or circulatory diseases, especially those which respond to a change of blood pressure, an increase in cardiac output and/or a change in micro-circulation.

Abstract: The present invention provides a process for increasing the quantum yield in the case of the oxidation of luminol or of a 7-dialkylaminonaphthalene-1,2-dicarboxylic acid hydrazide, each alkyl radical of which contains up to 3 carbon atoms, by a peroxide compound in the presence of peroxidase ( POD), wherein the reaction is carried out in the presence of fluorescein, the concentration of the fluorescein being in a concentration range which gives a quantum yield which is greater than the sum of the quantum yields of the individual chemiluminescing materials.The present invention also provides a reagent for the determination of POD, wherein it contains luminol or a 7-dialkylaminonaphthalene-1,2-dicarboxylic acid hydrazide, each alkyl radical of which contains up to 3 carbon atoms, fluorescein, a hydrogen peroxide provider, a buffer substance (pH 7.5 to 9) and optionally a sequestering agent.

Abstract: A tool for removal of a joint prosthesis intended for implantation in a body. The prosthesis includes a component adapted to be fixed to a long bone having an intramedullary canal and further includes an elongated male stem having a uniformly tapered outer surface. In order to accommodate the particular size of long bone to which the component is to be fixed, a properly sized female stem is attached to the male stem before the component is fixed to the long bone. The female stem is adapted to be received in the intramedullary canal for fixation thereto, and has a uniformly tapered inner surface, the angle of the taper being substantially similar to the angle of taper of the outer surface of the male stem. As a result, the male stem and female stem become locked together when the inner surface of the female stem engages the outer surface of the male stem. The tool serves to disengage is obtained the male stem from the female stem as well as to disengage the female stem from the bone.

Abstract: The present invention provides new tricyclic benzotriazoles of the general formula: ##STR1## wherein Z is a hydrogen atom or an acyl radical, Y is an oxygen or sulphur atom or two hydrogen atoms and X is an oxygen or sulphur atom or a >CR.sub.1 R.sub.2 or >NR.sub.3 group, R.sub.1 is a hydrogen atom or an alkyl, alkenyl or cycloalkyl radical, R.sub.2 is a hydrogen atom or an alkyl, alkenyl or cyano group or a carbonyl group substituted by a hydroxyl, alkyl, alkoxy, amino, alkylamino, dialkylamino or hydrazino group or R.sub.2, together with R.sub.1, represents a cycloalkylene radical or R.sub.1 and R.sub.2 together form an alkylidene or cycloalkylidene radical and R.sub.3 is a hydrogen atom or an alkyl radical; the tautomers thereof and the physiologically acceptable acid-addition salts thereof with inorganic and organic acids.

Abstract: The present invention provides carboxylic acid derivatives of the general formula: ##STR1## wherein R.sub.1 and R.sub.2, which can be the same or different, are optionally substituted aryl radicals or optionally substituted heterocyclic radicals, A is a straight-chained or branched, saturated or unsaturated alkylene chain containing up to 10 carbon atoms which can contain an oxygen, sulphur or nitrogen atom and is optionally substituted by a hydroxyl group, Y is an S(O).sub.n group or an oxygen atom, n is 0, 1 or 2 and B is a valency bond or a saturated or unsaturated alkylene radical containing up to 5 carbon atoms; as well as the physiologically acceptable salts, esters and amides thereof, with the proviso that(a) R.sub.1 and R.sub.2 are not simultaneously aryl radicals and(b) when an unsaturated alkylene chain is present which contains a heteroatom, the heteroatom is not connected to an unsaturated aliphatic carbon atom.

Abstract: The present invention provides benzimidazoles of the general formula: ##STR1## wherein R.sub.1, X, A, and R.sub.2 are as defined in the specification. The present invention also provides processes for the preparation of these new benzimidazoles and pharmaceutical compositions containing them, as well as intermediates for the preparation thereof.The new benzimidazoles are useful to treat heart or circulatory diseases which respond to a lowering of blood pressure, a positive inotropic action and/or an improvement in microcirculation.

Abstract: The present invention provides a composition containing guar flour in the form of tablets for oral administration, said tablets having been produced by dry pressing guar flour with a particle size of 60 to 500 .mu.m. in admixture with 5 to 30% of highly dispersed silica gel.

Abstract: The present invention is concerned with N- substituted aziridine-2-carboxylic acid derivatives, with pharmaceutical compositions containing these compounds and their immuno-stimulating and immuno-modulating activities.

Abstract: The present invention provides a process for the preparation of compounds of the general formula: ##STR1## in which X is a hydroxyl group and X.sub.1 is a hydrogen atom or a hydroxyl group, and especially of luciferin, by the reaction of D-cysteine with 2-cyanomono- or -dihydroxybenzothiazole obtained from 2-chloromono- or -dimethoxybenzothiazole via a demethylation, wherein the demethylation is accomplished by reaction with iodotrimethylsilane or with a mixture of phenyltrimethylsilane and iodine and hydrolysis under mild conditions of the silyl derivative formed.

Abstract: The present invention provides oxindole derivatives of the formula: ##STR1## wherein the various substituents are defined hereinbelow. The above compounds display nitrate-like as well as .beta.-blocking actions.

Abstract: A process for the preparation of S- or R-carbazole derivatives of the general formula: ##STR1## in which R is an unsubstituted or substituted amino radical and pharmacologically acceptable salts, by either reacting R-(-)-epichlorohydrin (for the S-carbazole derivative); or reacting an S-epoxide derivative of the general formula: ##STR2## in which R.sub.1 is the residue of a substituted sulphonic acid derivative (for the R-carbazole derivative); with 4-hydroxycarbazole and then with ammonia or a substituted amine of the general formula RH, and recovering the compound or converting it to a pharmacologically acceptable salt.The new R-(+)- and S-(-)-carbozole derivatives provided by the inventive process have unexpected beta blocking and vasodilatory properties and are useful in pharmaceutical compositions. R-(+)-carbazole derivatives are also useful for the treatment of glaucoma.